Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: A cohort study

Journal of Clinical Oncology

Volumn 29, Issue 21, 2011, Pages 2875-2882

  Kaur Knudsen, Diljit ^a   Bojesen, Stig E ^a,b   Tybjærg Hansen, Anne ^a,b,c   Nordestgaard, Børge G ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR; PROTEIN CHRNA3; PROTEIN CHRNA5; PROTEIN CHRNB4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CHROMOSOME 15Q; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE CLUSTER; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LUNG CANCER; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, NICOTINIC; RISK ASSESSMENT; RISK FACTORS; SMOKING; STROKE; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 79960703027     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.9870     Document Type: Article

References (25)

1. Barnes PJ: Chronic obstructive pulmonary disease. N Engl J Med 343:269-280, 2000
2. Benowitz NL: Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment. Prog Cardiovasc Dis 46:91-111, 2003
3. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194-1210, 1999
4. Pelucchi C, Bosetti C, Negri E, et al: Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol 3:327-340, 2006 (Pubitemid 43871794)
5. Saccone SF, Hinrichs AL, Saccone NL, et al: Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16:36-49, 2007 (Pubitemid 46152543)
6. Amos CI, Wu X, Broderick P, et al: Genomewide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40:616-622, 2008 (Pubitemid 351601203)
7. Hung RJ, McKay JD, Gaborieau V, et al: A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452:633-637, 2008 (Pubitemid 351483367)
8. Liu P, Vikis HG, Wang D, et al: Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst 100:1326-1330, 2008
9. Pillai SG, Ge D, Zhu G, et al: A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genet 5:e1000421, 2009
10. Thorgeirsson TE, Geller F, Sulem P, et al: A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642, 2008 (Pubitemid 351483366)
11. Nordestgaard BG, Benn M, Schnohr P, et al: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298:299-308, 2007 (Pubitemid 47080484)
12. Schnohr P, Jensen JS, Scharling H, et al: Coronary heart disease risk factors ranked by importance for the individual and community: A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. Eur Heart J 23:620-626, 2002 (Pubitemid 35204246)
13. Zacho J, Tybjaerg-Hansen A, Jensen JS, et al: Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 359:1897-1908, 2008
14. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, et al: Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 300:2142-2152, 2008
15. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
16. Tobacco and Genetics Consortium: Genomewide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 42:441-447, 2010
17. Caporaso N, Gu F, Chatterjee N, et al: Genomewide and candidate gene association study of cigarette smoking behaviors. PLoS One 4:e4653, 2009
18. Le Marchand L, Derby KS, Murphy SE, et al: Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res 68:9137-9140, 2008
19. Spitz MR, Amos CI, Dong Q, et al: The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 100:1552-1556, 2008
20. Stevens VL, Bierut LJ, Talbot JT, et al: Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev 17:3517-3525, 2008
21. Schlaepfer IR, Hoft NR, Collins AC, et al: The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry 63:1039-1046, 2008
22. Bierut LJ, Stitzel JA, Wang JC, et al: Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165:1163-1171, 2008
23. Truong T, Hung RJ, Amos CI, et al: Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: A pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 102:959-971, 2010
24. Wang J, Spitz MR, Amos CI, et al: Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer 116:3458-3462, 2010
25. Wang Y, Broderick P, Matakidou A, et al: Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis 31:234-238, 2010